Unichem gets US FDA nod for Pithampur bulk drug unit

2009 November 10

by Srinivas

Unichem Laboratories has informed that the company has received approval for its bulk drug [API] facility situated at Pithampur from US FDA. With this approval, both bulk drug facilities situated at Roha, Maharashtra and Pithampur, Madhya Pradesh are duly approved by US FDA. The company’s formulation facilities at Goa and Ghaziabad are already approved by US FDA.

Your Ad Here

No related posts.

Comments are closed for this entry.

This work is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 India License

Vigilance Theme by Jestro

DISCLAIMER : Stock trading involves high risk and one can lose Substantial amount of money.The recommendations made herein Do not constitute an offer to sell or solicitation to buy any of the Securities mentioned. No representations can be made that recommendations contained herein will be profitable or they will Not result in losses. Readers using the information contained herein are solely responsible for their actions. The information is obtained from sources deemed to be reliable but is not guaranteed as to accuracy and completeness. The above recommendations are based on technical analysis only.

News about Indian Stock Markets

Unichem gets US FDA nod for Pithampur bulk drug unit

Recent Posts

Categories

Archives

Search

Authors

What I'm Doing...